… ProQR spins out Amylon Therapeutics as a privately-held company focused on … Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of … that the company has spun out Amylon Therapeutics (Amylon), a privately-held company focused on the development …
… FDA Fast Track designation and ODD in the U.S. and Europe. Amylon Therapeutics was spun out as a privately-held company … candidate for Usher syndrome 2A patients, and the team at Amylon, which we spun out as a privately-owned company that … the trial in 2018 subject to a partnership. Spin-out of Amylon Therapeutics In September, ProQR spun out Amylon …
… 2018, with interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on … Axiomer ® . We are also thrilled with the spin out of Amylon as a privately-held company to a group of private and … investors, while maintaining our majority ownership in Amylon. This enables the program to attract external funding …